Press Release
March 17, 2014
Theracos reports positive outcomes from a 96-week Phase 2 study of THR1442, a highly specific SGLT2 inhibitor, for the treatment of Type 2 Diabetes Theracos, Inc., www.theracos.com , a privately held biotechnology company located in Marlborough, Massachusetts, today announced the results of […]
Read More ยป
Fatal error: Uncaught Error: Call to undefined function wp_pagenavi() in /home1/acollins/public_html/wp-content/themes/theracos/loop-news.php:13
Stack trace:
#0 /home1/acollins/public_html/wp-includes/template.php(574): require()
#1 /home1/acollins/public_html/wp-includes/template.php(531): load_template('/home1/acollins...', false)
#2 /home1/acollins/public_html/wp-includes/general-template.php(167): locate_template(Array, true, false)
#3 /home1/acollins/public_html/wp-content/themes/theracos/archive.php(36): get_template_part('loop-news')
#4 /home1/acollins/public_html/wp-includes/template-loader.php(75): include('/home1/acollins...')
#5 /home1/acollins/public_html/wp-blog-header.php(19): require_once('/home1/acollins...')
#6 /home1/acollins/public_html/index.php(17): require('/home1/acollins...')
#7 {main}
thrown in
/home1/acollins/public_html/wp-content/themes/theracos/loop-news.php on line
13